In my opinion EX1s philosophy is much like their (somewhat related by personel) stem cell company CYP.
they believe they have a novel process for large scale production.
Relying on their process being picked up by some majors in this space.
Trials and patents on the use of them is far too risky and much too hard work.
Decide for yourself!
Ann: Quarterly Activities Report and Appendix 4C, page-23
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.78M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.1¢ | 1.9¢ | $10.23K | 512.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 62819 | 1 |
View Market Depth
| Last trade - 14.43pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.1¢ |
Change
0.000 ( 10.5 %) |
||||
| Open | High | Low | Volume | ||
| 1.9¢ | 2.1¢ | 1.9¢ | 41961 | ||
| Last updated 12.43pm 17/06/2024 ? | |||||
| TYP (ASX) Chart |
